Page 16 - Axonics Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mizuho Reaffirms Buy Rating for Axonics (NASDAQ:AXNX)

Mizuho Reaffirms Buy Rating for Axonics (NASDAQ:AXNX)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Hong kongDannyl dearenAlmanack investment partnersRoyal bankNeedham companyAxonics incTower research capitalHong kong ltdSecurities exchange commissionAxonics company profileArcadia investment management corpGet free reportExchange commissionInvestment partnersFinancial advisorsKong ltd

Axonics, Inc (NASDAQ:AXNX) Receives $78 44 Consensus Target Price from Brokerages

Axonics, Inc (NASDAQ:AXNX) Receives $78 44 Consensus Target Price from Brokerages
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesDannyl dearenVanguard group incAmerica corpSecurities exchange commissionFred alger managementNeedham companyNorges bankAxonics incGet free reportExchange commissionAlger managementJane street groupStreet groupGet freeAxonics daily

Oak Ridge Investments LLC Reduces Stake in Axonics, Inc (NASDAQ:AXNX)

Oak Ridge Investments LLC lowered its position in Axonics, Inc. (NASDAQ:AXNX – Get Rating) by 6.0% in the 1st quarter, HoldingsChannel.com reports. The fund owned 54,966 shares of the company’s stock after selling 3,493 shares during the quarter. Oak Ridge Investments LLC’s holdings in Axonics were worth $2,999,000 as of its most recent filing with […]

Dannyl dearenFred alger managementVanguard group incLord abbettOak ridge investmentsSecurities exchange commissionExchange commissionAxonics incNorges bankNeedham companyGet ratingBridge investmentsAlger managementJane street groupStreet groupTrading down

Axonics, Inc (NASDAQ:AXNX) Receives Average Recommendation of Moderate Buy from Analysts

Axonics, Inc. (NASDAQ:AXNX – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12 month target price among […]

Dannyl dearenNeedham companyTower research capitalAxonics incAlmanack investment partnersAltshuler shaham ltdGet ratingTruist financialShaham ltdInvestment partnersFinancial advisorsResearch capitalAxonics dailyNasdaq axnx

Axonics, Inc (NASDAQ:AXNX) Receives $78 44 Consensus Target Price from Analysts

Axonics, Inc. (NASDAQ:AXNX – Get Rating) has been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target among […]

Dannyl dearenGroup one tradingRaymond james financial services advisors incUs bancorpYork mellon corpAxonics company profileNeedham companyAxonics incJpmorgan chase coSecurities exchange commissionGet ratingExchange commissionJames financial services advisorsNew york mellon corpAxonics daily